Kawamoto Shinya, Koda Ryo, Yoshino Atsunori, Takeda Tetsuro, Ueda Yoshihiko
Nihon Jinzo Gakkai Shi. 2014;56(7):1097-103.
A 62-year-old-Japanese man had a history of probable granulomatosis with polyangiitis (GPA) from 7 years previously, showing kidney and vasculitis symptoms with PR3-ANCA (864 EU) without renal biopsy. Remission with normalization of renal function and urinary findings was induced by corticosteroid therapy. Prednisolone (PSL) was tapered to 5 mg/day and maintained for 6.5 years with a low positive titer of PR3-ANCA. After 7 years of remission, he was referred to our hospital because of arthralgia, fever, general fatigue and appetite loss with apparent urinary abnormality, increased serum Cr (1.8 mg/dL) and C reactive protein (CRP : 30.1 mg/dL). On admission, he showed a high titer of PR3-ANCA (> 300 U/mL). Renal biopsy demonstrated the existence of the pauci-immune type of severe crescentic necrotizing glomerulonephritis, tubulo-interstitial damage and perivascular granuloma. He was diagnosed as relapse of GPA (kidney-localized type) without upper respiratory tract (E) and lung (L) symptoms. Accordingly, he received steroid pulse therapy leading to improvement of these symptoms and renal function. Oral PSL at the dosage of 40 mg/day was administered after steroid pulse therapy, and then tapered to 20 mg/day. Cyclophosphamide was added within 8 weeks. He was discharged 8 weeks after treatment with a decreased level of Cr (1.5 mg/dL) and PR3-ANCA (244 U/mL). After discharge, PSL was tapered to 10 mg/day during the course of stability resulting in a further improved level of Cr (1.2 mg/dL), PR3-ANCA 40 U/mL in the outpatient clinic. In Japan, PR3-ANCA-positive GPA has a lower incidence than MPO-ANCA-positive microscopic vasculitis. In GPA, the kidney-localized (K) type without upper respiratory tract (E, L) symptoms is rare. Histologically, not only necrotizing crescentic glomerulonephritis but also perivascular granuloma in the kidney are very rare and interesting.
一名62岁的日本男性,7年前曾患疑似肉芽肿性多血管炎(GPA),出现肾脏和血管炎症状,PR3-ANCA(864 EU)阳性,但未进行肾活检。皮质类固醇治疗诱导肾功能和尿液检查结果恢复正常,病情缓解。泼尼松龙(PSL)逐渐减量至5mg/天,并维持6.5年,PR3-ANCA呈低滴度阳性。病情缓解7年后,因关节痛、发热、全身乏力和食欲减退,伴有明显的尿液异常、血清肌酐(Cr)升高(1.8mg/dL)和C反应蛋白(CRP:30.1mg/dL),他被转诊至我院。入院时,他的PR3-ANCA滴度很高(>300U/mL)。肾活检显示存在寡免疫型严重新月体坏死性肾小球肾炎、肾小管间质损伤和血管周围肉芽肿。他被诊断为GPA复发(肾脏局限型),无呼吸道(E)和肺部(L)症状。因此,他接受了类固醇冲击治疗,这些症状和肾功能得到改善。类固醇冲击治疗后,口服PSL剂量为40mg/天,然后逐渐减量至20mg/天。在8周内加用环磷酰胺。治疗8周后出院,Cr水平(1.5mg/dL)和PR3-ANCA(244U/mL)降低。出院后,在病情稳定过程中,PSL逐渐减量至10mg/天,门诊复查时Cr水平进一步改善(1.2mg/dL),PR3-ANCA为40U/mL。在日本,PR3-ANCA阳性的GPA发病率低于MPO-ANCA阳性的显微镜下血管炎。在GPA中,无呼吸道(E、L)症状的肾脏局限型(K)很少见。组织学上,不仅坏死性新月体肾小球肾炎,而且肾脏中的血管周围肉芽肿都非常罕见且有趣。